sAfety PerfoRmance chitOsan osteOarthritis ViscosupplEmentation

NAUnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 15, 2018

Primary Completion Date

May 15, 2019

Study Completion Date

December 15, 2019

Conditions
Knee Osteoarthritis
Interventions
DEVICE

Investigational device coded KIO014

Innovative chitosan-based biomaterial intended for intraarticular injection.

DEVICE

Durolane(r) as control device

Crosslinked hyaluronic acid-based biomaterial intended for intraarticular injection.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Kiomed Pharma

INDUSTRY

NCT03679208 - sAfety PerfoRmance chitOsan osteOarthritis ViscosupplEmentation | Biotech Hunter | Biotech Hunter